Cytokines

Paradoxical gastrointestinal effects of interleukin-17 blockers
Pankti Mehta, Able Lawrence, Amita Aggarwal

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218719; DOI: 10.1136/annrheumdis-2020-218719
Correspondence on ‘Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells’
Honglin Wang, Lei Niu

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218825; DOI: 10.1136/annrheumdis-2020-218825
Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case–control study’
Martin Sebastian Winkler, Peter Korsten, Claudia Binder, Björn Tampe

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218836; DOI: 10.1136/annrheumdis-2020-218836
Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis
Kamala Vanarsa, Sanam Soomro, Ting Zhang, Briony Strachan, Claudia Pedroza, Malavika Nidhi, Pietro Cicalese, Christopher Gidley, Shobha Dasari, Shree Mohan, Nathan Thai, Van Thi Thanh Truong, Nicole Jordan, Ramesh Saxena, Chaim Putterman, Michelle Petri, Chandra Mohan

Annals of the Rheumatic Diseases Oct 2020, 79 (10) 1349-1361; DOI: 10.1136/annrheumdis-2019-216312
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial
Seza Ozen, Eldad Ben-Cherit, Ivan Foeldvari, Gil Amarilyo, Huri Ozdogan, Steven Vanderschueren, Katherine Marzan, J Michelle Kahlenberg, Elise Dekker, Fabrizio De Benedetti, Isabelle Koné-Paut

Annals of the Rheumatic Diseases Oct 2020, 79 (10) 1362-1369; DOI: 10.1136/annrheumdis-2020-217419
Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
Achille Aouba, Aurelie Baldolli, Loïk Geffray, Renaud Verdon, Emmanuel Bergot, Nicolas Martin-Silva, Aurélien Justet

Annals of the Rheumatic Diseases Oct 2020, 79 (10) 1381-1382; DOI: 10.1136/annrheumdis-2020-217706
Response to: ‘Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome’ by van den Hoogen et al
Mariana J Kaplan, Kerry A Casey

Annals of the Rheumatic Diseases Oct 2020, 79 (10) e136; DOI: 10.1136/annrheumdis-2019-215811
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al
Piero Ruscitti, Federico Bruno, Onorina Berardicurti, Chiara Acanfora, Viktoriya Pavlych, Pierpaolo Palumbo, Alessandro Conforti, Francesco Carubbi, Ilenia Di Cola, Paola Di Benedetto, Paola Cipriani, Davide Grassi, Carlo Masciocchi, Annamaria Iagnocco, Antonio Barile, Roberto Giacomelli

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218909; DOI: 10.1136/annrheumdis-2020-218909
Response to: ‘Tofacitinib for the treatment of polyarteritis nodosa: a literature review’ by Akiyama et al
Doron Rimar, Abid Awisat, Lisa Kaly, Gleb Slobodin, Itzhak Rosner, Michael Rozenbaum, Shira Ginsberg, Elina Starosvetsky, Ayelet Alpert, Shai Shen-Orr

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218790; DOI: 10.1136/annrheumdis-2020-218790
Tocilizumab for the treatment of polyarteritis nodosa: a systematic literature review
Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218710; DOI: 10.1136/annrheumdis-2020-218710

Main menu

Cytokines

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cytokines

Pages